Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Minoxidil boosts elastin production, potentially helping skin diseases.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Vitamin D3 may protect rat hair follicles from radiation damage.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

New treatments like plant extracts, nanocarriers, and 3D bioprinting show promise for hair loss, but more research is needed.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Gut bacteria differences may influence alopecia areata.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Careful management of blood thinners is crucial for lupus patients with APS.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Phototherapy can help treat hair loss in alopecia areata.

88% phenol is effective for treating alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.